Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 418331Generated: October 27, 2026

1,2-Dichloroethane → Formate

https://huagongshe.com/reaction/418331

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,2-DichloroethaneHCID 11—
Reactant4-MethylmorpholineHCID 7972—
Reactant1-HydroxybenzotriazoleHCID 75771—
Reactant1-Boc-piperidin-3-yl-propionic acidHCID 2756824—
ReactantHCID 28712232HCID 28712232—
SolventDimethylformamideHCID 6228—
SolventDichloromethaneHCID 6344—
ProductFormateHCID 283412.5%
ProductHCID 25055320HCID 25055320—

Reaction Steps

3-Nitrophenylacetic acid (136 mg, 0.75 mmol), EDC (240 mg, 1.25 mmol) and HOBt (135 mg, 1 mmol) were combined in a reaction vial, and DMF (1 mL) was added, followed by N-methylmorpholine (0.137 mL, 1.25 mmol). The resulting solution was agitated for 1 h, after which time 3,4-dimethoxyaniline (115 mg, 0.75 mmol) was added and the reaction mixture was agitated overnight. The reaction mixture was then diluted with 6 mL dichloromethane, and the resulting mixture was washed with 1 N HCl (2×2 mL), NaHCO3 (satd. aq., 2×2 mL), and brine (1×2 mL), dried, and the solvents were evaporated to 216 mg of a dark oil. The product was purified by preparative HPLC using an acetonitrile/water/formic acid gradient to provide 36 mg (15% yield) of the intermediate N-(3,4-dimethoxy-phenyl)-2-(3-nitro-phenyl)-acetamide. This intermediate (36 mg, 0.114 mmol) was dissolved in methanol (1 mL) and ammonium formate (69 mg, 1.1 mmol) and then Pd/C (5 mg) was added. The reaction vial was sealed and heated to 45° C. overnight. The reaction mixture was filtered, and the mother liquors were diluted with ethyl acetate (10 mL). This mixture was washed with water (2×5 mL) and brine (1×5 mL), dried and concentrated to provide 10 mg (31% yield) of the desired intermediate 2-(3-amino-phenyl)-N-(3,4-dimethoxy-phenyl)-acetamide, which was used directly. Subsequently, 3-(2-carboxy-ethyl)-piperidine-1-carboxylic acid tert-butyl ester (12.9 mg, 0.05 mmol), EDC (11.5 mg, 0.06 mmol) and HOBt (8.1 mg, 0.06 mmol) were combined in a reaction vial, and DMF (1 mL) was added, followed by N-methylmorpholine (0.007 mL, 0.06 mmol). The resulting solution was agitated for 30 minutes, after which time the intermediate prepared above, 2-(3-amino-phenyl)-N-(3,4-dimethoxy-phenyl)-acetamide (10 mg, 0.035 mmol) was added. The reaction mixture was agitated overnight, then diluted with 5 mL dichloromethane, and the resulting mixture was washed with 1N HCl (2×2 mL), NaHCO3 (saturated aqueous, 1×2 mL), and brine (1×2 mL), dried, and concentrated to 19 mg (72%) of an amber oil, which was dissolved in dichloromethane (1 mL) and treated with SCX (136 mg, 0.12 mmol). The resulting mixture was agitated overnight. The reaction mixture was then filtered and the solids were washed with dichloromethane (2×2 mL) and methanol (2×2 mL). The product was eluted with NH3 in methanol (7 N, 2×2 mL), and the solvents were evaporated. The resulting residue was purified by preparative HPLC using an acetonitrile/water/formic acid gradient providing the title compound as a formate salt (6.5 mg, 38% yield), MS analysis electrospray, 426 (M+H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08093266B2
Source datasetuspto-grants-2012_01
ORD IDord-4c6a35b954a2488597e90d156f578688
Source noteuspto-grants-2012_01